Signal Evolution and Infarction Risk for Apparent Diffusion Coefficient Lesions in Acute Ischemic Stroke Are Both Time- and Perfusion-Dependent by An, H. et al.
Signal evolution and infarction risk for ADC lesions in acute
ischemic stroke are both time and perfusion dependent
Hongyu An, D.Sc1,*, Andria L. Ford, M.D2,*, Katie Vo, M.D.3, William J. Powers, M.D4, Jin-
Moo Lee, M.D, Ph.D2,†, and Weili Lin, Ph.D1,†
1Department of Radiology and Biomedical Research Imaging Center, University of North Carolina
at Chapel Hill
2Department of Neurology, Washington University, School of Medicine
3Department of Radiology, Washington University, School of Medicine
4Department of Neurology, University of North Carolina at Chapel Hill
Abstract
Background and Purpose—This study aimed to examine the temporal relationship between
tissue perfusion and apparent diffusion coefficient (ADC) changes within 6 hours of ischemic
stroke onset and how different reperfusion patterns may affect tissue outcome in ADC lesion.
Methods—Thirty-one participants were sequentially imaged at 3 hours, 6 hours and 1 month
post stroke. Three regions of interest (ROIs) were defined within initial ADC lesions:
ROI(1)reperf3hr hyper-acute reperfusion (within 3 hours), ROI(2)reperf6hr acute reperfusion (3-6
hours), and ROI(3)nonreperf no reperfusion (by 6 hours). For each ROI, changes of ADC (ΔADC)
from 3 to 6 hours and risks of infarction were examined.
Results—The magnitude of initial ADC reduction was similar in all three ROIs (P=0.51). ΔADC
were strongly associated with reperfusion (P<0.0001) but not with initial ADC reduction (P=0.83).
ΔADC in ROI(1)reperf3hr, ROI(2)reperf6hr were significantly larger than that of ROI(3)nonreperf
(P<0.05). Positive ΔADC were obtained from 3 to 6 hours in ROI(1)reperf3hr that had restored
perfusion prior to 3 hours, demonstrating a temporal delay between reperfusion and ADC changes.
Risk of infarction were significantly higher in ROI(3)nonreperf than those in ROI(1)reperf3hr and
ROI(2)reperf6hr.
Conclusions—Improvement of ADC did not occur coincidently with reperfusion but showed a
temporal delay. Regions with similar initial ADC reductions at 3 hours had different evolution of
ADC and infarction risks depending on when or if tissue reperfused. These findings provide a
physiological basis for the observation that a single ADC measurement at a fixed time after stroke
onset may not accurately predict tissue outcome.
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Magnetic resonance diffusion weighted imaging (DWI) is widely utilized in clinical practice
to depict acute ischemic stroke lesions. It has been demonstrated that compromised blood
flow leads to a reduction of the apparent diffusion coefficient (ADC) during ischemia 1, 2.
ADC reduction may be observed as early as minutes after stroke onset 3. Conversely, DWI
lesions have been found to reverse in various settings including shortly after thrombolysis or
a few days after stroke onset 4–6. However, the temporal behavior of ADC lesion
improvement after reperfusion during the first hours after stroke onset has not been
documented in humans. Moreover, it has not been thoroughly investigated whether the
presence of reperfusion and its timing directly affect the final fate of an ADC lesion. In a
rapid sequential DWI study in cats, Davis et al found that ADC reduction and recovery did
not occur concurrently with stroke onset or reperfusion but rather evolved progressively
over 5–10 minutes after these events 7. Based on this animal study, we hypothesized that a
temporal delay may also exist between tissue reperfusion and ADC improvement in acute
human stroke. This temporal delay may explain, in part, why ADC reduction is not a reliable
predictor of ischemic tissue outcome 8, particularly since DWI images are usually acquired
at a single time point after stroke onset in current clinical practice. An improved
understanding of the relationship between perfusion and diffusion changes may aid in
clinical decision-making using MRI.
In this study of sequential MR imaging in patients with acute ischemic stroke, we examined
the temporal evolution of abnormal ADC in brain regions exhibiting three different
reperfusion patterns during the hyper-acute phase of ischemia. The infarction risk for each
of these patterns was measured and compared.
Participants and Methods
Participants and Inclusion Criteria
This is a retrospective analysis of data from a prospectively collected observational study of
serial MRIs performed in acute ischemic stroke patients at a large tertiary care referral
center, admitting over 800 ischemic stroke patients per year. After Institutional Review
Board approval, the study enrolled consecutive patients within 3.5 hours of stroke onset
based on the following pre-specified inclusion criteria: clinically-suspected acute cortical
ischemic stroke; age ≥ 18 years; NIHSS ≥ 5; and patient or patient’s next of kin capable of
informed consent. Exclusion criteria included bilateral strokes or any acute endovascular or
surgical intervention. Both tPA-treated and untreated patients were included. Patients were
given IV tPA according to NINDS tPA trial protocol 4. In tPA-treated patients, tPA
administration was begun prior to all MR imaging studies without causing any delay in
time-to tPA-treatment or any deviation from standard monitoring practices.
Magnetic Resonance Imaging
Thirty-one participants were serially scanned with MRI at 3 time points (tp): within 3.5
hours (tp1), at 6 hours (tp2), and at 1 month (tp3) after stroke onset. Tp1 scan was acquired
as early as possible. Participants treated with tPA were imaged immediately after initiation
of tPA infusion. One month follow-up scans were obtained in twenty-six participants, the
remaining five participants were not available due to premature death (n=1) or early
withdrawal (n=4) from the study.
MR images were acquired on a 3T Siemens whole body Trio system (Siemens Medical
Systems, Erlangen, Germany). Imaging protocols, including DWI, FLAIR, T1, and PWI
using dynamic susceptibility contrast (DSC), were identical for both tp1 and tp2. DWI
images were acquired with a single-shot, spin echo, echo planar imaging (EPI) sequence
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(TR/TE=2900/90 ms, b= 0, 500, 1000 s/mm2; 3-axis diffusion encoding; 20 slices with a
slice thickness of 5 mm). The imaging parameters for the FLAIR sequence were: TR/TE =
10000/115 ms; inversion time (TI) = 2500 ms; a matrix of 512 × 416 pixels, and 20 slices.
T1 weighted images were obtained using a 3D MPRAGE sequence (TR/TE=1520/3.69 ms,
TI=800ms, Flip Angle=8, matrix = 256 × 256 × 144, voxel size= 1 × 1 × 1 mm3, parallel
imaging with an acceleration factor of 2). PWI images were acquired with a T2*-weighted
gradient echo EPI sequence (TR/TE= 1500/43 ms, 14 slices with a slice thickness of 5 mm,
matrix= 128×128). This sequence was repeated 50 times and Gadolinium diethylenetriamine
penta-acetic acid (Gd-DTPA, 0.1 mmol/kg) was injected at the completion of the 5th
measure.
Data Analysis
In PWI images, the change of MR signal induced by the bolus passage of contrast agent was
first converted to ΔR2*/concentration curve. Subsequently, voxels within the MCA of the
contralateral hemisphere were manually chosen to obtain an arterial input function. A
singular value decomposition (SVD) method was utilized to calculate cerebral blood flow
(CBF), cerebral blood volume (CBV) and derive the mean transit time (MTT=CBV/CBF) 9
Six parameter rigid image registration was performed to align MTT, ADC, and FLAIR
images from the same participant across all time points using FSL 3.2 (FMRIB, Oxford,
UK). To minimize the inclusion of cerebrospinal fluid (CSF), voxels with an ADC value
greater than 100×10−5 mm2/s were removed from data analysis 6. Blood from early
hemorrhagic transformation (HT) may affect ADC at tp2. To minimize its effect on ADC,
we examined the T2* weighted DSC images at tp2 for each patients. Hypointense regions
were then manually outlined as HT and excluded from data analysis. Mean MTT and ADC
values were obtained from a ROI that encompasses the whole contralateral hemisphere for
each participant.
Voxels with ADC values < mean-2*SD of the contralateral hemisphere were defined as
abnormal. Three regions of interest (ROIs) were defined within tp1 abnormal ADC regions
corresponding to three different reperfusion patterns to (1) evaluate the temporal evolution
of each of these three ADC lesions and (2) their respective tissue outcomes. MTT was
chosen to define perfusion status because MTT is uniform across gray and white matter
(unlike CBF or CBV), allowing for use of a single threshold across both gray and white
matter 9. Hypoperfusion was defined using MTT > 4 seconds longer than the mean
contralateral hemispheric. Fig 1 shows a schematic representation of the definition of three
ROIs. ROI(1)reperf3hr was defined as voxels with abnormal ADC at tp1 but normal MTT at
tp1 and tp2 (labeled as “1”, Fig. 1), representing an ADC lesion that reperfused prior to tp1
imaging (<3hr). ROI(2)reperf6hr was defined as voxels with abnormal ADC and MTT at tp1,
but normal MTT at tp2 (labeled as “2”, Fig. 1), representing an ADC lesion that reperfused
between tp1 (3 hours) and tp2 (6 hours). ROI(3)nonreperf was defined as voxels with
abnormal ADC at tp1 and abnormal MTT at tp1 and tp2 (labeled as “3”, Fig. 1),
representing an ADC lesion that did not reperfuse. Note our definition of ADC lesion was
based on tp1 ADC maps only and three ROIs were defined using tp1 ADC and tp1 and tp2
MTT. Therefore, no ADC lesion is delineated at tp2 in Fig. 1 to avoid confusion. In all
ROIs, isolated regions smaller than 1 ml were removed to minimize artifacts due to potential
misalignment and spurious findings caused by random noise.
Mean ADC values from these ROIs at tp1 and tp2 were obtained to examine the temporal
evolution of ADC between the two tps on an individual participant basis. ADC changes
from tp1 to tp2 were computed as ΔADC=ADC_tp2-ADC_tp1 in all three ROIs. A positive
ΔADC was considered as an improvement of ADC. A generalized linear model (SAS 9.2,
SAS Institute Inc., Cary, NC, USA) was utilized to perform an analysis of covariance
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(ANCOVA) to evaluate whether reperfusion status (reperfusion <3hr, reperfusion 3-6 hr,
and without reperfusion) and/or tp1 ADC values might affect ΔADC. ΔADC was the
dependent variable, while tp1 ADC values and reperfusion status were the independent
variables in the model.
Final lesions were manually outlined as hyperintense regions on tp3 FLAIR. The defined
final lesions were mapped onto the tp1 and tp2 images. Based on the overlap between final
lesion and each ROI, risk of infarction was calculated as the ratio of the number of infarcted
voxels to the total number of voxels in a specific ROI on an individual patient basis. To
evaluate whether the risk of infarction differed among all three ROIs, one-way analysis of
variance (ANOVA) with Newman-Keuls multiple comparison post test was performed.
P<0.05 was considered statistically significant.
Results
Thirty-one acute ischemic stroke patients were enrolled after obtaining written informed
consent. Their characteristics are summarized in Table 1. At tp1, the mean ADC of
contralateral hemispheres was 81.1± 2.0×10−5 mm2/s, which is similar to published
reports 6, 10. The threshold for abnormal ADC, defined as two standard deviations below the
normal value at tp1, was 64.3± 3.9×10−5 mm2/s (approximately 21% below normal values).
Representative tp1 and tp2 MTT, tp1 and tp2 ADC, one month FLAIR and overlaid ROIs
from three participants are shown in Figure 2.
Temporal change of ADC
In this study, two sequential MR scans were used to determine reperfusion status within the
first 6 hrs after stroke onset in both tPA treated and untreated patients. Given that only 8
patients did not receive tPA treatment in our study cohort, we did not perform separate
analyses for tPA treated and untreated patients.
Tp1 ADC values were similarly reduced in all three ROIs (P=0.51) regardless of the initial
or different subsequent reperfusion status (Fig 3a-c). The median and interquartile range
(IQR) of tp1 ADC were 54.2 (IQR [52.5, 56.9]) ×10−5 mm2/s, 52.3 (IQR [49.8, 55]) ×10−5
mm2/s, and 52 (IQR [48.9, 55.8]) ×10−5 mm2/s for ROI(1)reperf3hr, ROI(2)reperf6hr and
ROI(3)nonreperf, respectively.
ROI(1)reperf3hr, representing hyper-acute reperfusion (< 3 hours), was identified in 12
participants. Of which, 2 (17%) were not treated with tPA (marked in red, Fig 3a).
ROI(2)reperf6hr, representing reperfusion between tp1 (3 hours) and tp2 (6 hours), was
detected in 9 participants. Of which, 1 (11%) was not treated with tPA (marked in red, Fig
3b). ROI(3)nonreperf, representing initially abnormal ADC and abnormal perfusion at tp1 and
without evidence of reperfusion at tp2, was detected in 19 participants. Of which, 5 (26%)
were untreated patients.
Scatter plots of ΔADC in the three predefined ROIs were given in Figure 3d. ΔADC were
strongly associated with reperfusion status (P<0.0001, ANCOVA analysis) but was not
associated with tp1 ADC (P=0.83). The median (IQR) ΔADC were 15.7 (IQR [8.4, 20.1])
×10−5 mm2/s, 14.3 (IQR [3.9, 21.1]) ×10−5 mm2/s, and −2.3 (IQR [−4.4, 0.6]) ×10−5 mm2/s
in ROI(1)reperf3hr, ROI(2)reperf6hr and ROI(3)nonreperf, respectively. ΔADC were not
significantly different for ROI(1)reperf3hr, ROI(2)reperf6hr, but ΔADC in both reperfused
ROIs were significantly larger than that of ROI(3)nonreperf (P<0.05). That ROI(1)reperf3hr
showed a similar increase in ADC to ROI(2)reperf6hr even though already reperfused at 3
hours, demonstrates that a temporal dissociation between reperfusion and ADC change
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occurred in this tissue. The small number of non-tPA-treated patients prevents us from
discerning whether tPA induced reperfusion or spontaneous reperfusion might have a
different impact on subsequent ADC evolution.
Risk of Infarction
Risks of infarction were plotted for all ROIs in Figure 4. The median and IQR risks of
infarction were 64.2% (IQR [56.2%, 82.7%]) for ROI(1) reperf3hr, 84.3% (IQR [30.2%,
88.5%]) for ROI(2) reperf6hr, and 94.4% (IQR [83.5%, 97.9%]) for ROI(3)nonreperf (Fig. 4).
One-way ANOVA analysis showed significantly different risks of infarction among the
three ROIs (P<0.01). Newman-Keuls post tests further revealed that risks of infarction in
ROI(3)nonreperf were significantly higher than those in ROI(1)reperf3hr and ROI(2) reperf6hr
(P<0.05). The fact that all three groups had similar initial ADC reductions but different risks
of infarction highlights the failure of a single ADC measurement at 3 hours after stroke
onset to accurately reflect tissue outcome and the importance of concurrent and subsequent
perfusion status in this determination.
Discussion
DWI is widely utilized in the clinical setting of acute stroke to delineate ischemic injury.
Given its common use, it is of critical importance to improve our understanding of ADC
evolution during and after ischemia. Consistent with previous reports, we found that acute
changes in ADC are dependent on tissue reperfusion, but not on initial severity of ADC
reduction 6. Moreover, a temporal delay between reperfusion and ADC improvement was
observed in some tissue. Regions with similar ADC reductions at 3 hours had different
tissue outcomes depending on whether or when reperfusion occurred.
Temporal delay between reperfusion and ADC improvement
Despite the clinical utility of ADC to identify ischemic injury 11, challenges remain to
explain why acute ADC lesions might or might not undergo infarction12, 13 and why an
absolute ADC threshold for infarction has not been identified 14. We have shown that
similar ADC abnormalities at tp1 correspond to different tissue fates, depending on
concurrent and subsequent perfusion status (Fig 4). Positive ΔADC were obtained from tp1
to tp2 in ROI(1)reperf3hr that had restored perfusion prior to tp1 (Fig. 3a). It demonstrates
that depending on the elapsed time after reperfusion, different ADC values might be
obtained (e.g. tp1 and tp2 ADC in ROI(1)reperf3hr ) in tissue with already improved perfusion
(Fig. 3a). Our findings are consistent with a previous animal study showing ADC reversal
subsequent to tissue reperfusion 7 and previous MR spectroscopy and PET studies
demonstrating heterogeneous cellular metabolic injury in regions with similar ADC 2, 15.
Taken together, this evidence may help to explain why a single time-point ADC threshold to
predict tissue outcome has not been identified.
The biophysical mechanisms of ADC lesion reversal have not been fully determined.
Previous animal studies 16, 17 demonstrated that extracellular [K+] began to revert to normal
about 40 minutes after reperfusion. Meanwhile, electrical excitability was shown to recover
after 8 to 15 minutes; synaptic excitability and low-frequency spontaneous electrocortical
activity were restored after 30 to 60 minutes and one to two hours, respectively, after
reperfusion. This progressive recovery of energy metabolism and ion homeostasis after
reperfusion may be related to delayed ADC improvement after reperfusion.
ADC improvement vs. Tissue recovery
The median risks of infarction for the two ROIs that exhibited reperfusion, ROI(1)reperf3hr
and ROI(2) reperf6hr, were 64.2% and 84.3%, respectively, indicating that regions with acute
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ADC improvement (positive ΔADC) within 6 hrs after symptom onset still showed a high
probability of infarction. This finding is consistent with previous animal and human
studies 12, 13, 18.
Several mechanisms may be responsible for the discrepancy between acute ADC increase
and 1 month tissue infarction. Ringer et al examined the histological condition of ischemic
tissue exhibiting ADC reversal in rats after 30 minutes of middle cerebral artery occlusion
(MCAO)19, followed by successful reperfusion. MRI scans were compared with histology
by using neuronal, astrocytic markers, and heat shock protein 72 (HSP72) 19. Their results
suggested that neurons already exhibited structural damage and stress despite ADC lesion
reversal, while astrocytes were morphologically intact. Other studies reported that reversed
ADC regions had varying degrees of neuronal injury 13, 18, 20. Moreover, several factors
such as calcium overload, free radical formation, and lactic acidosis 21, 22 might trigger a
delayed mitochondrial dysfunction leading to the death of these regions with normalized
ADC 23–25.
Study limitations and other issues
In this study, only two time points were acquired during the hyper-acute phase of ischemia
to characterize lesion evolution. While additional time-points will be needed to fully
document the temporal relationship between perfusion and diffusion changes during hyper-
acute and acute stages of ischemia, this is impractical for human studies. In addition, the
number of non-tPA-treated patients was too few to determine whether tPA treatment might
uniquely impact our findings. Given these limitations, to the best of our knowledge, this
study is the first to reveal that a temporal delay exist between reperfusion and ADC
improvement in human acute stroke.
Of note, there is an important difference between the previously reported pseudo-
normalization and the ADC evolution observed in our study. Pseudonormalization (normal
ADC, but subsequent infarct evolution on T2 weighted images) occurs between 1 and 7 days
after stroke onset in humans. This phenomenon might be due to increased cerebral water
content associated with vasogenic edema 6, 26–28. In contrast, ADC improvement in our
study which occurred during the first 6 hours after ischemia onset is unlikely caused by
vasogenic edema but rather in response to tissue reperfusion. Therefore, the underlying
pathophysiological mechanism of the acute ADC improvement in this study likely reflects a
different process from ADC pseudo-normalization observed days after stroke.
Clinical implications
Regions with a similar ADC reduction at 3hrs had different final outcomes depending on
whether and when reperfusion occurred. In regions with reperfusion within 3 hrs after stroke
onset, less than 40% of tissue survived. In regions with reperfusion between 3–6 hrs after
stroke onset, risk of infarction varied in a large range with a median risk of infarction greater
than 80%. Because ADC may still increase over time in tissue that already reperfused,
different ADC values could be obtained depending on the elapsed time after reperfusion.
Therefore, a single time-point ADC measurement does not fully reflect the disease process
and outcome. Beyond diagnosing acute ischemic, interpretation of ADC for tissue outcome,
particularly in the presence of reperfusion, must be performed with caution.
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A schematic representation of the definition of three ROIs within tp1 abnormal ADC
regions. Yellow color outlines MTT lesion at tp1 and tp2, and orange color outlines ADC
lesion at tp1. Region 1 represents ROI(1)reperf3hr that exhibits abnormal ADC at tp1but
normal MTT at tp1 and tp2; Region 2 represents ROI(2)reperf6hr that has abnormal ADC and
MTT at tp1 and normal MTT at tp2; and region 3 represents ROI(3)nonreperf that shows
abnormal ADC at tp1 and abnormal MTT at tp1 and tp2.
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Representative MRI images of the participants exhibiting the three ROIs defined in Figure 1.
Shown are MTT tp1 and tp2 (1st and 2nd columns), ADC tp1 and tp2 (3rd and 4th columns),
and FLAIR at tp3 (5th column). Each representative ROI (defined in Figure 1) was overlaid
onto the tp1 ADC (6th columns): pt 1, ROIreperf3hr (green); pt 2, ROIreperf6hr (blue); and pt 3,
ROInonreperf (red).
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Mean ADC from ROIreperf3hr (a), ROIreperf6hr (b), and ROInonreperf (c) for each individual
participant at tp1 and tp2 after stroke onset. Perfusion status was labeled at both tp1 and tp2
in (a) to (c). A scatter plot of ΔADC in the three ROIs (d). † denotes statistical different
ΔADC between a ROI and ROInonreperf. tPA treated patients were marked in black, while
untreated patients were highlighted using red.
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Risk of infarction in the three ROIs (box=25th-75th percentile; bars = 10th-90th percentile). †
denotes statistical difference between a specific ROI and ROInonreperf using Newman-Keuls
multiple comparison.
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Age, year (mean±SD) 61±14
Women, n (%) 13 (42%)
Stroke Syndrome R MCA: 17, L MCA:13, L ICA:1






Time from Symptom Onset
 Admission 0.9±0.6
 Treatment (OTT) 1.9±0.4
 tp1 (hr) 2.9±0.8
 tp2 (hr) 6.3±0.3
 tp3 (day) 29±10
Time from tPA-Treatment to scan
 tp1 (hr) 0.7±0.4





MCA=middle cerebral artery, ICA=internal cerebral artery, L=left, R=right.
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